PVR source and collect biospecimen through an extensive network of affiliated hospitals in Ukraine, Turkey, and Georgia, distributing them worldwide. Collecting human biospecimens becomes a seamless process when partnering with us, as we offer end-to-end solutions.
We prioritize ethical practices by obtaining clinical materials only after receiving approval from respected bodies like IRB/IEC.
We strictly adhere to international standards that protect the rights and well-being of individuals participating in our studies
They willingly provide consent and put their signature on the ICF
We handle clinical data with care, ensuring complete anonymity, in accordance with ethical guidelines such as GCP
Biospecimens are biological materials taken from the human body, such as tissue, blood, plasma, and urine. They are crucial for medical research, particularly in understanding diseases like cancer. These specimens are often collected during medical procedures like biopsies or surgeries and can be stored for future research. Notably, they may contain critical biomolecules like DNA, RNA, and proteins, which are essential for studying the mechanisms of diseases. Biorepositories or 'libraries' store these biospecimens, making them accessible for clinical or research purposes.
Retrospective collection refers to the use of biospecimens that were initially collected for clinical or diagnostic purposes and are later used for research. This can include remnant samples (leftover specimens from clinical procedures) or waste samples (biospecimens not needed for a clinical purpose and would otherwise be discarded).The collection and usage of these specimens for research might not always require upfront consent if certain conditions are met, such as the research posing minimal risk and the impracticality of carrying out the research if consent were mandated.
Prospective collection involves gathering biospecimens explicitly for research purposes. In this approach, participants are identified before the collection, and their biospecimens are gathered as part of the study's interventions.This type of research generally requires informed consent from subjects before collecting their biospecimens, especially when the samples are intended for specific research purposes known at the time of collection.
Biospecimens are pivotal in bridging molecular information with clinical data, allowing researchers to understand diseases at a molecular level. They are used in various fields like genomics, proteomics, and pharmacogenomics to study gene functions, disease progression, and patients' drug responses.Human biospecimens enable researchers to isolate the molecular characteristics of diseases and link those findings to clinical progression. This helps in developing targeted therapies, understanding disease subtypes, and creating diagnostic tests.Well-characterized biospecimens have accelerated research in areas like breast cancer and leukemia, leading to the development of targeted treatments like Herceptin and Gleevec.
